Literature DB >> 16390348

mu-Opiate receptor agonists -- a new pharmacological approach to prevent motion sickness?

Bärbel Otto1, Rudolf L Riepl, Carsten Otto, Joachim Klose, Paul Enck, Sibylle Klosterhalfen.   

Abstract

AIMS: Stress hormones might be involved in motion sickness. The influence of loperamide on kinetosis-induced nausea and stress hormone release was investigated in a placebo-controlled, cross-over study.
METHODS: Standardized rotation around the vertical axis combined with head movements was used to induce nausea 3 h after 16 mg loperamide or placebo (n = 8). Plasma antidiuretic hormone (ADH), adrenocorticotropic hormone (ACTH) and nausea ratings were investigated.
RESULTS: After loperamide nausea was significantly lower (P < 0.02). ACTH (P < 0.05) and ADH levels (P < 0.02) increased significantly in both settings, but were lower after loperamide.
CONCLUSIONS: The susceptibility to develop kinetosis-induced nausea and stress hormone release is decreased by loperamide, although the site of action remains speculative.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16390348      PMCID: PMC1884979          DOI: 10.1111/j.1365-2125.2005.02505.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Pavlovian conditioning of taste aversion using a motion sickness paradigm.

Authors:  S Klosterhalfen; A Rüttgers; E Krumrey; B Otto; U Stockhorst; R L Riepl; T Probst; P Enck
Journal:  Psychosom Med       Date:  2000 Sep-Oct       Impact factor: 4.312

2.  Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro.

Authors:  C J Auernhammer; G K Stalla; M Lange; A Pfeiffer; O A Müller
Journal:  J Clin Endocrinol Metab       Date:  1992-08       Impact factor: 5.958

3.  Suppression of vagus-mediated pancreatic polypeptide release by the mu-opiate receptor agonist loperamide in man.

Authors:  R L Riepl; B Reichardt; C J Auernhammer; G Beier; J Schopohl; G K Stalla; P Lehnert
Journal:  Br J Clin Pharmacol       Date:  1996-09       Impact factor: 4.335

Review 4.  New pharmacologic approaches to the prevention of space/motion sickness.

Authors:  R L Kohl; S MacDonald
Journal:  J Clin Pharmacol       Date:  1991-10       Impact factor: 3.126

5.  Sex-specific adaptation of endocrine and inflammatory responses to repeated nauseogenic body rotation.

Authors:  Nicolas Rohleder; Bärbel Otto; Jutta M Wolf; Joachim Klose; Clemens Kirschbaum; Paul Enck; Sibylle Klosterhalfen
Journal:  Psychoneuroendocrinology       Date:  2005-09-06       Impact factor: 4.905

6.  The effect of two antidiarrhoeal drugs on the psychosocial adjustment to illness in chronic functional diarrhoea.

Authors:  D L Dumitrascu; Mihaela Stanculete; Ioana Mitrea; Diana Mihaela Dumitrascu; Adriana Farcas
Journal:  Rom J Intern Med       Date:  2004

Review 7.  Mechanisms of action of loperamide.

Authors:  L A Ooms; A D Degryse; P A Janssen
Journal:  Scand J Gastroenterol Suppl       Date:  1984

8.  Axonal transport of opiate receptors in capsaicin-sensitive neurones.

Authors:  P M Laduron
Journal:  Brain Res       Date:  1984-02-27       Impact factor: 3.252

9.  Apomorphine-induced nausea in humans: release of vasopressin and pancreatic polypeptide.

Authors:  M Feldman; W K Samson; T M O'Dorisio
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

10.  Loperamide: evidence of interaction with mu and delta opioid receptors.

Authors:  G Giagnoni; L Casiraghi; R Senini; L Revel; D Parolaro; M Sala; E Gori
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

View more
  3 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Antihistamines for motion sickness.

Authors:  Nadine Karrim; Ryan Byrne; Nombulelo Magula; Yougan Saman
Journal:  Cochrane Database Syst Rev       Date:  2022-10-17

Review 3.  What is nausea? A historical analysis of changing views.

Authors:  Carey D Balaban; Bill J Yates
Journal:  Auton Neurosci       Date:  2016-07-16       Impact factor: 3.145

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.